WT-4869

N/A

Report date: 2022/04/07 16:39:42

Base Information

Drug NameWT-4869
Drug Alias NameSynthetic peptide vaccine derived from the Wilms’tumor gene 1(Sumitomo Pharma)WT-4869
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Synthetic peptide vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMyelodysplastic Syndromes
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesSumitomo Dainippon
China Registration ClassN/A

Develop Information

Active CompaniesSumitomo Dainippon
Inactive CompaniesN/A
Active IndicationsMyelodysplastic Syndromes
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A